These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron. Goldsmith B Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626 [No Abstract] [Full Text] [Related]
44. Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCT. Musso M; Scalone R; Crescimanno A; Bonanno V; Polizzi V; Porretto F; Bianchini C; Perrone T Bone Marrow Transplant; 2010 Jan; 45(1):123-7. PubMed ID: 19483762 [TBL] [Abstract][Full Text] [Related]
45. Chemotherapy-induced nausea and vomiting: state of the art in 2006. Schwartzberg L J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138 [TBL] [Abstract][Full Text] [Related]
46. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma. Slabý J; Trnený M; Procházka B; Klener P Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251 [TBL] [Abstract][Full Text] [Related]
47. Is palonosetron also effective for opioid-induced and post-discharge nausea and vomiting? Apfel CC; Jukar-Rao S Br J Anaesth; 2012 Mar; 108(3):371-3. PubMed ID: 22337957 [No Abstract] [Full Text] [Related]
48. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation. Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147 [TBL] [Abstract][Full Text] [Related]
49. Controlling conditioning-related emesis in children undergoing bone marrow transplantation. Mehta NH; Reed CM; Kuhlman C; Weinstein HJ; Parsons SK Oncol Nurs Forum; 1997 Oct; 24(9):1539-44. PubMed ID: 9348595 [TBL] [Abstract][Full Text] [Related]
51. Practical selection of antiemetics. Flake ZA; Scalley RD; Bailey AG Am Fam Physician; 2004 Mar; 69(5):1169-74. PubMed ID: 15023018 [TBL] [Abstract][Full Text] [Related]
52. Mechanisms and management of nausea and emesis. Dicato M Oncology; 1996 Jun; 53 Suppl 1():1-3. PubMed ID: 8692544 [No Abstract] [Full Text] [Related]
53. Editorial Comment to Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients. Rozzi A; Lanzetta G Int J Urol; 2015 Oct; 22(10):915. PubMed ID: 26153730 [No Abstract] [Full Text] [Related]
54. Serotonin antagonists for nausea and vomiting. Gastroenterol Nurs; 2014; 37(2):184-6. PubMed ID: 24691090 [No Abstract] [Full Text] [Related]
55. Nausea & vomiting in end-stage cancer. Haughney A Am J Nurs; 2004 Nov; 104(11):40-8; quiz 49. PubMed ID: 15616448 [No Abstract] [Full Text] [Related]
56. The management of nausea and vomiting in palliative care. Thompson I Nurs Stand; 2004 Nov 3-9; 19(8):46-53; quiz 54. PubMed ID: 15552468 [TBL] [Abstract][Full Text] [Related]
57. Palliation of nausea and vomiting in malignancy. Mannix K Clin Med (Lond); 2006; 6(2):144-7. PubMed ID: 16688970 [No Abstract] [Full Text] [Related]
58. The prevalence of nausea and vomiting in pediatric patients receiving home parenteral nutrition. Nicol JJ; Hoagland RL; Heitlinger LA Nutr Clin Pract; 1995 Oct; 10(5):189-92. PubMed ID: 8552012 [TBL] [Abstract][Full Text] [Related]